Nanjing Regenecore Biotech Co., Ltd.

This early-stage study tests a new drug called RJK-RT2831 in 71 adults with blood cancers. The main goals are to check safety, find the best dose, and see if the drug works. It is a first-in-human trial, so the focus is on understanding side effects and how the body processes the…

This study tests an experimental injection called RC1416 in 180 adults with moderate to severe COPD. The goal is to see if it can reduce the number of serious flare-ups and improve lung function compared to a placebo. Participants will receive either the drug or a dummy shot, and…